| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/16/2002 | CA2425980A1 Foggy |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/15/2002 | EP1205546A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205541A1 Procedure for the long-term cultivation of organo-typic slices of brain and other postnatal tissues, in particular of adult mammals |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1204790A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof |
| 05/15/2002 | EP1204760A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 05/15/2002 | EP1204757A1 Neutral cerebral-sphingomyelinase |
| 05/15/2002 | EP1204756A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204746A2 Sentrin-specific human proteases senp1-3 |
| 05/15/2002 | EP1204739A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204674A2 Methods and compositions for inhibiting polypeptide accumulation associated with neurological disorders |
| 05/15/2002 | EP1147186A4 In vitro activated gamma delta lymphocytes |
| 05/15/2002 | EP1096941A4 Bone marrow cells as a source of neurons for brain and spinal cord repair |
| 05/15/2002 | EP0633941B1 Synthetic eukaryotic promoters containing two inducible elements |
| 05/15/2002 | CN1349559A Noninvasive detection of colorectal cancer and other gasrointestinal pathology |
| 05/15/2002 | CN1348990A Culture medium for tissue culture of devirused potato and its prepn |
| 05/14/2002 | US6388172 Phytochrome regulated transcription factor for control of higher plant development |
| 05/14/2002 | US6388169 Maize orthologues of bacterial RecA proteins |
| 05/14/2002 | US6388113 Extraction from seeds |
| 05/14/2002 | US6388068 Nucleotide sequences of promoters; for efficient industrial production of exogenous polypeptides in plant xylem sap |
| 05/14/2002 | US6388064 Human 2-19 protein homologue, z219a |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6388055 Mouse CC-CKR5 receptor polypeptide |
| 05/14/2002 | US6388052 Amino acid sequence of nuclear factor of activated t lymphocytes, a transcription factor; immunomodulators |
| 05/14/2002 | US6387702 Recombining dna segments of competence genes to create library, screening library for improved competence in non-mammalian cells, repeating until desired level achieved, then transforming into cell |
| 05/14/2002 | US6387701 Method of identifying tumor antigens that elicit a T-cell response |
| 05/14/2002 | US6387698 Polyclonal antiserum produced by immunzing animal with tumor rejection antigen precursor |
| 05/14/2002 | US6387693 Cells having ability to form extracellular cartilage matrix are brought into a cell space where they settle on a plate in a culture medium for producing extracellular cartilage matrix |
| 05/14/2002 | US6387682 Amino acid sequence of polypeptide with cysteine protease activity; treatment of bone disorders such as osteoporosis; anticarcinogenic agents; antitumor agents; antimetastasis agents |
| 05/14/2002 | US6387681 Method for cloning and expression of NHEI restriction endonuclease in E. coli. |
| 05/14/2002 | US6387676 Human cDNAs encoding polypeptides having kinase functions |
| 05/14/2002 | US6387674 Has activity against betal amyloid 1-42 protein in beta sheet conformation; treatment of alzheimer's disease amyloidosis, atherosclerosis, and creutzfeld-jakob disease |
| 05/14/2002 | US6387671 Sending electrical current from one point to another point through electroconductive tissue, creating image of tissue, adjusting an electrical parameter for desired degree of electroporation |
| 05/14/2002 | US6387663 Fusion protein of collagen binding domain and angiogenesis modulating domain; treatment of cardiovascular disorders; antiischemic agents |
| 05/14/2002 | US6387662 Constructing recombinant dna encoding core protein, envelope 1 protein, and envelope 2 protein; expressing dna in eukaryotic host cell and allowing assembly; then isolating non-infectious particle |
| 05/14/2002 | US6387658 PCNA-associated cell cycle proteins, compositions and methods of use |
| 05/14/2002 | US6387657 Amino acid sequence of wnt-1-induced secreted protein; anticarcinogenic agents; antitumor agents; treatment of arteriosclerosis; diagnosis of related disorders |
| 05/14/2002 | US6387656 Gene encoding MNR2 and uses thereof |
| 05/14/2002 | US6387643 Amino acid sequence; antiinflammatory agents; antiarthritic agents; anticarcinogenic agents |
| 05/14/2002 | US6387639 Ma family polypeptides and anti-Ma antibodies |
| 05/14/2002 | US6387638 Heregulin variants |
| 05/14/2002 | US6387616 Torsin, torsin genes, and methods of use |
| 05/14/2002 | US6387396 In gene therapy and in in vitro and in vivo transfection |
| 05/14/2002 | US6387395 N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| 05/14/2002 | US6387377 Acellular antibordetella vaccine |
| 05/14/2002 | US6387376 Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis |
| 05/14/2002 | US6387372 Polypeptides from mycrobacterium paratuberculosis |
| 05/14/2002 | US6387371 Specifically binds to an extracellular domain of the her2 receptor in an amount effective to inhibit growth of cancer cells |
| 05/14/2002 | US6387369 Cardiac muscle regeneration using mesenchymal stem cells |
| 05/14/2002 | US6387367 Human mesenchymal stem cells |
| 05/14/2002 | US6387366 Reducing the biological activity of tissue factor, tf; bone marrow cells; antisense oligonucleotide or ribozyme which inhibits expression of tissue factor (tf) or an antibody that binds to and inhibits tf |
| 05/14/2002 | CA2167090C Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 05/14/2002 | CA2144601C Recombinant type ii collagenase from clostridium histolyticum and its use for isolating cells and groups of cells |
| 05/14/2002 | CA2104678C Protein-induced morphogenesis |
| 05/10/2002 | WO2002037101A2 A method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| 05/10/2002 | WO2002036807A2 Compositions and methods relating to breast specific genes and proteins |
| 05/10/2002 | WO2002036806A2 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | WO2002036792A2 Dna expression vectors |
| 05/10/2002 | WO2002036790A2 Influenza virus vector for infection of dendritic cells |
| 05/10/2002 | WO2002036789A2 Methods of modifying eukaryotic cells |
| 05/10/2002 | WO2002036787A2 Herbicide-tolerant plants through bypassing metabolic pathway |
| 05/10/2002 | WO2002036784A1 Transgenic animals for analysing cyp3a4 cytochrome p450 gene regulation |
| 05/10/2002 | WO2002036782A2 Novel glyphosate n-acetyltransferase (gat) genes |
| 05/10/2002 | WO2002036776A1 Improvement of plant flower type targeting mads box gene |
| 05/10/2002 | WO2002036771A2 Imaging, diagnosis and treatment of disease |
| 05/10/2002 | WO2002036770A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits |
| 05/10/2002 | WO2002036761A2 Compositions and methods for the diagnosis of cancer |
| 05/10/2002 | WO2002036751A2 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/10/2002 | WO2002036750A2 T-cells specifically recognizing minor histocompatibility antigen(s) and uses thereof for eliminating target cells |
| 05/10/2002 | WO2002036749A2 Postmortem stem cells |
| 05/10/2002 | WO2002036748A2 Methods for depleting and isolating alloreactive and antigen-reactive t cells from hematopoietic donor cells |
| 05/10/2002 | WO2002036741A2 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | WO2002036735A2 Dry powder cells and cell culture reagents and methods of production thereof |
| 05/10/2002 | WO2002036733A2 Cd36 as a heat shock protein receptor and uses thereof |
| 05/10/2002 | WO2002036631A1 Method of screening antiplatelet |
| 05/10/2002 | WO2002036627A2 Interferons, uses and compositions related thereto |
| 05/10/2002 | WO2002036625A2 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | WO2002036611A2 Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 05/10/2002 | WO2002036170A2 Vector system for transducing the positive neurons |
| 05/10/2002 | WO2002036076A2 Cell lines expressing a mch receptor |
| 05/10/2002 | WO2002035992A2 Tissue-engineered vascular structures |
| 05/10/2002 | WO2002035990A2 Supported lattice for cell cultivation |
| 05/10/2002 | WO2002015927A8 High mannose proteins and methods of making high mannose proteins |
| 05/10/2002 | WO2002014479A3 Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells |
| 05/10/2002 | WO2002011743B1 Treatment of prostate cancer |
| 05/10/2002 | WO2002000885A9 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 05/10/2002 | WO2001098338A3 Fluorescent proteins |
| 05/10/2002 | WO2001094949A3 Soluble cd1 compositions and uses thereof |
| 05/10/2002 | WO2001092477A3 Three-dimensional skin model |
| 05/10/2002 | WO2001092475A3 Method for producing a recipient-specific tissue transplant or tissue implant |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |